Previous Page  7 / 8 Next Page
Information
Show Menu
Previous Page 7 / 8 Next Page
Page Background

Page 30

Notes:

Volume 2

allied

academies

June 11-13, 2018 | London, UK

Neurology and Neuroscience

6

th

International Conference on

T

he field of Brain Mapping has been evolving rapidly in the

last few years. Brain Mapping is defined as the study of the

anatomy and function of the brain and spinal cord through the

use of a variety of techniques, including: imaging (including

intra-operative, microscopic, endoscopic, and multi-modality

imaging), immunohistochemistry, molecular & optogenetics

methods, stem cell and cellular biology, engineering

(material, electrical and biomedical), neurophysiology, and

nanotechnology. Importantly, the field has gone from being

defined by imaging alone to include not only imaging but

also molecular/cellular and nano-level mapping with detailed

genetic and connectomic maps.

In 2013 the Society for Brain Mapping & Therapeutics

(SBMT), the Brain Mapping Foundation (BMF), and a few

other organizations successfully helped the White House to

formulate the Brain Research through Advancing Innovative

Neurotechnologies (BRAIN) initiative. The Organization has

also started a G20 Summit/Neuroscience-20 initiative as well

as Brain technology and Innovation Park (BTIP). BMF has been

funding a major partnerships with NASA and Federal Labs in

order to integrate nanotechnology devices, imaging, cellular

and molecular studies, artificial intelligence, supercomputing,

and stem cell biology.

In this presentation, I will explain how SBMT’s G20 Summit/

Neuroscience-20 and BTIP advancing neuroscience globally

by buidling international partnerships. I will demonstrate how

we have impacted the field through innovation, integration,

translation and commercialization of neurotechnologies.

I will also discuss how emerging technologies such as

nanoneuroscience, nanoneurosurgery, nanobioelectronics,

neurophotonics, predictive modeling combined and Artificial

Intelligence (AI) could provide game changing intraoperative

brain mapping systems.

Speaker Biography

Babak Kateb is a neuroscientist with more than 20 years of research experience.

His research has been focused on introduction of game changing diagnostics and

therapeutics into clinical neuroscience. He is founding chairman and CEO of the Society

for Brain Mapping and Therapeutics (SBMT), President and Scientific Director of the

Brain Mapping Foundation and Director of National Center for Nano-Bio-Electronics

and Director of Brain Technology and Innovation Park (BTIP); He is a recipient of

NASA Tech Brief Award (2011) for his pioneering work on sniffing cancer cells using

NASA’s electronic nose and the SBMT Pioneer in Medicine Award (2015) for designing

an FDA-approved device for microwaving cancer. He has edited two textbooks:

“Textbook of Nanoneuroscience and Nanoneurosurgery”, and “Neurophotonic and

Brain Mapping”. He has been involved in global neuroscience legislation/policies. He

has chaired 7 briefings on Brain Mapping at the US Congress, chaired brain mapping

days at the Canadian (2012) and Australian (2016) Parliaments. He has been one of the

key players in President Obama’s BRAIN initiative and co-author of the G20 summit/

Neuroscience-20, and author of BTIP Initiative.

e:

Babak.Kateb@worldbrainmapping.org

Babak Kateb

Society for Brain Mapping & Therapeutics, USA

From Nanoneurosurgery to supercomputing, and AI to smart intraoperative

microscopy